Traders should consider positioning for near-term upside as the stock is likely to trade close to the $21.50 offer price once the tender offer commences. Arbitrage opportunities may exist if shares trade below the offer price, though risks include deal delays or failure to secure antitrust approval.
Price Chart
Executive Summary
Servier has agreed to acquire Day One Biopharmaceuticals (DAWN) for $21.50 per share in cash, representing a total equity value of approximately $2.5 billion. The offer includes a 68% premium over Day One's closing price on March 5, 2026, and is expected to close in Q2 2026, pending regulatory approval and shareholder tender.
Key Financial Metrics
Key Facts
- Servier is acquiring Day One Biopharmaceuticals for $21.50 per share in cash
- Total equity value of the transaction is approximately $2.5 billion
- Offer represents a 68% premium over DAWN's March 5, 2026 closing price and 86% over one-month VWAP
- Transaction expected to close in Q2 2026, subject to antitrust clearance and shareholder tender
- Day One's Board recommends shareholders tender their shares
Financial Impact
$2.5 billion total equity value, $21.50 per share cash consideration
Risk Factors
- Deal is contingent on U.S. antitrust clearance, which could delay or block the transaction
- Completion requires tender of a majority of outstanding shares, exposing the deal to shareholder holdouts
- Potential for competing bids or litigation could alter or terminate the agreement
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3251033 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 4, 2026 21w ago | 15-12G | — | awaiting T+1 | — | — |
Apr 23, 2026 23w ago | 25-NSE | $21.53 $21.53 | · 0.00% | ▼ −0.78% | — |
Apr 23, 2026 23w ago | 8-K | $21.53 $21.53 | · 0.00% | ▼ −0.78% | — |
Apr 17, 2026 23w ago | 10-K/A | $21.48 $21.49 | ▲ +0.05% | ▲ +0.70% | — |
Mar 6, 2026 30w ago | Press Release | $21.20 $21.33 | ▲ +0.61% | ▼ −0.23% | — |
Feb 24, 2026 31w ago | 8-K | $10.92 $10.65 | ▼ −2.43% | ▼ −1.88% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access